| Amelia Lopez, | |
|
3449 E Rezanof Dr, Kodiak, AK 99615-6952 | |
| (907) 486-3479 | |
| (907) 486-3479 |
| Full Name | Amelia Lopez |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 3449 E Rezanof Dr, Kodiak, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639220288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | F57435 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amelia Lopez, 3449 E Rezanof Dr, Kodiak, AK 99615-6952 Ph: () - | Amelia Lopez, 3449 E Rezanof Dr, Kodiak, AK 99615-6952 Ph: (907) 486-3479 |
News Archive
Ingen Technologies, Inc., a leading manufacturer of respiratory medical devices, recently announced today that the SMART Nasal Cannula is a featured new product at the upcoming MedTrade convention in Las Vegas from May 10 through May 13, 2010. The Las Vegas MedTrade convention is the largest home health care expo in the world. Ingen is an exhibitor and will be part of the New Product showcase at MedTrade. The SMART Nasal Cannula is the Next-Generation of cannulas that improve oxygen therapy and reduce expenditures.
Cervical cancer is preventable, thanks to the development of the human papillomavirus (HPV) vaccine. Various strains of HPV, a sexually transmitted infection, play a significant role in the event of cervical cancer. Now, the U.S. can eradicate cervical cancer within the next 20 years, according to a new study.
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
UnitedHealth Group today reported first quarter results, including better-than-projected membership and services growth and effective cost management across its businesses. Financial metrics were in line with or better than Company expectations.
› Verified 9 days ago